Hyperlipidemia Impaired Innate Immune Response to Periodontal Pathogen Porphyromonas gingivalis in Apolipoprotein E Knockout Mice

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Lei, Lang ^a   Li, Houxuan ^a   Yan, Fuhua ^b   Xiao, Yin ^c  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOLIPOPROTEIN E GENE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GRAM NEGATIVE INFECTION; HYPERLIPIDEMIA; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; KNOCKOUT MOUSE; MACROPHAGE ACTIVATION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PORPHYROMONAS GINGIVALIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEINS E; BACTEROIDACEAE INFECTIONS; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; HYPERLIPIDEMIAS; IMMUNITY, INNATE; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERIODONTAL DISEASES; PHAGOCYTOSIS; PORPHYROMONAS GINGIVALIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, PATTERN RECOGNITION; TRANSCRIPTION FACTOR RELA; TRANSCRIPTOME;

EID: 84881585190     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071849     Document Type: Article

References (65)

1. Yu WH, Hu H, Zhou Q, Xia Y, Amar S, (2010) Bioinformatics analysis of macrophages exposed to Porphyromonas gingivalis: implications in acute vs. chronic infections. PLOS ONE 5: e15613.
2. Morran MP, Alexander LA, Slotterbeck BD, McInerney MF, (2009) Dysfunctional innate immune responsiveness to Porphyromonas gingivalis lipopolysaccharide in diabetes. Oral Microbiol Immunol 24: 331-339.
3. Noack B, Jachmann I, Roscher S, Sieber L, Kopprasch S, et al. (2000) Metabolic diseases and their possible link to risk indicators of periodontitis. J Periodontol 71: 898-903.
4. Fentoglu O, Oz G, Tasdelen P, Uskun E, Aykac Y, et al. (2009) Periodontal status in subjects with hyperlipidemia. J Periodontol 80: 267-273.
5. Awartani F, Atassi F, (2010) Evaluation of periodontal status in subjects with hyperlipidemia. J Contemp Dent Pract 11: 033-040.
6. Chu X, Newman J, Park B, Nares S, Ordonez G, Iacopino AM, (1999) In vitro alteration of macrophage phenotype and function by serum lipids. Cell Tissue Res 296: 331-337.
7. Cutler CW, Iacopino AM, (2003) Periodontal disease: links with serum lipid/ triglyceride levels? Review and new data. J Int Acad Periodontol 5: 47-51.
8. Tomofuji T, Azuma T, Kusano H, Sanbe T, Ekuni D, et al. (2006) Oxidative damage of periodontal tissue in the rat periodontitis model: effects of a high-cholesterol diet. FEBS Lett 580: 3601-3604.
9. He J, Gu D, Reynolds K, Wu X, Muntner P, et al. (2004) Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation 110: 405-411.
10. Ford ES, Li C, Pearson WS, Zhao G, Mokdad AH, (2010) Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol 140: 226-235.
11. Wang QT, Wu ZF, Wu YF, Shu R, Pan YP, et al. (2007) Epidemiology and preventive direction of periodontology in China. J Clin Periodontol 34: 946-951.
12. Maekawa T, Takahashi N, Tabeta K, Aoki Y, Miyashita H, et al. (2011) Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLOS ONE 6: e20240.
13. Nakarai H, Yamashita A, Takagi M, Adachi M, Sugiyama M, et al. (2011) Periodontal disease and hypertriglyceridemia in Japanese subjects: potential association with enhanced lipolysis. Metabolism 60: 823-829.
14. Nazzal D, Therville N, Yacoub-Youssef H, Garcia V, Thomsen M, et al. (2010) Apolipoprotein E-deficient mice develop an anti-Chlamydophila pneumoniae T helper 2 response and resist vascular infection. J Infect Dis 202: 782-790.
15. Madan M, Bishayi B, Hoge M, Messas E, Amar S, (2007) Doxycycline affects diet- and bacteria-associated atherosclerosis in an ApoE heterozygote murine model: cytokine profiling implications. Atherosclerosis 190: 62-72.
16. Liang S, Domon H, Hosur KB, Wang M, Hajishengallis G, (2009) Age-related alterations in innate immune receptor expression and ability of macrophages to respond to pathogen challenge in vitro. Mech Ageing Dev 130: 538-546.
17. Wang M, Shakhatreh MA, James D, Liang S, Nishiyama S, et al. (2007) Fimbrial proteins of porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J Immunol 179: 2349-2358.
18. Hazenbos WL, den Berg BMv, van't WJW, Mooi FR, van FR, (1994) Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes. Infect Immun 62: 4818-4824.
19. Zhou Q, Leeman SE, Amar S, (2009) Signaling mechanisms involved in altered function of macrophages from diet-induced obese mice affect immune responses. Proc Natl Acad Sci U S A 106: 10740-10745.
20. Gyurko R, Boustany G, Huang PL, Kantarci A, Van Dyke TE, et al. (2003) Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis. Infect Immun 71: 4917-4924.
21. Alayan J, Ivanovski S, Gemmell E, Ford P, Hamlet S, et al. (2006) Deficiency of iNOS contributes to Porphyromonas gingivalis-induced tissue damage. Oral Microbiol Immunol 21: 360-365.
22. Garlet GP, (2010) Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 89: 1349-1363.
23. Shamshiev AT, Ampenberger F, Ernst B, Rohrer L, Marsland BJ, et al. (2007) Dyslipidemia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity. J Exp Med 204: 441-452.
24. Netea MG, de Bont N, Demacker PN, Kullberg BJ, Jacobs LE, et al. (1998) Lipoprotein(a) inhibits lipopolysaccharide-induced tumor necrosis factor alpha production by human mononuclear cells. Infect Immun 66: 2365-2367.
25. Madenspacher JH, Draper DW, Smoak KA, Li H, Griffiths GL, et al. (2010) Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes. J Immunol 185: 1660-1669.
26. Baitsch D, Bock HH, Engel T, Telgmann R, Muller-Tidow C, et al. (2011) Apolipoprotein E induces antiinflammatory phenotype in macrophages. Arterioscler Thromb Vasc Biol 31: 1160-1168.
27. Roselaar SE, Daugherty A, (1998) Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res 39: 1740-1743.
28. Martens GW, Arikan MC, Lee J, Ren F, Vallerskog T, et al. (2008) Hypercholesterolemia impairs immunity to tuberculosis. Infect Immun 76: 3464-3472.
29. de Bont N, Netea MG, Demacker PN, Verschueren I, Kullberg BJ, et al. (1999) Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 40: 680-685.
30. Ali K, Middleton M, Pure E, Rader DJ, (2005) Apolipoprotein E suppresses the type I inflammatory response in vivo. Circ Res 97: 922-927.
31. Fukada SY, Silva TA, Saconato IF, Garlet GP, Avila-Campos MJ, et al. (2008) iNOS-derived nitric oxide modulates infection-stimulated bone loss. J Dent Res 87: 1155-1159.
32. Shamshiev AT, Ampenberger F, Ernst B, Rohrer L, Marsland BJ, et al. (2007) Dyslipidemia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity. J Exp Med 204: 441-452.
33. Hajishengallis G, Krauss JL, Liang S, McIntosh ML, Lambris JD, (2012) Pathogenic microbes and community service through manipulation of innate immunity. Adv Exp Med Biol 946: 69-85.
34. Roger T, Lugrin J, Le RD, Goy G, Mombelli M, et al. (2011) Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 117: 1205-1217.
35. Gibot S, Kolopp-Sarda MN, Bene MC, Bollaert PE, Lozniewski A, et al. (2004) A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 200: 1419-1426.
36. Netea MG, Azam T, Ferwerda G, Girardin SE, Kim SH, et al. (2006) Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors. J Leukoc Biol 80: 1454-1461.
37. Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE, et al. (2003) Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci U S A 100: 12247-12252.
38. Natoli G, Saccani S, Bosisio D, Marazzi I, (2005) Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat Immunol 6: 439-445.
39. Zabel U, Baeuerle PA, (1990) Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA. Cell 61: 255-265.
40. Bosisio D, Marazzi I, Agresti A, Shimizu N, Bianchi ME, et al. (2006) A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity. EMBO J 25: 798-810.
41. Lf C, Fischle W, Verdin E, Greene WC, (2001) Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science (80-) 293: 1653-1657.
42. Foey AD, Parry SL, Williams LM, Feldmann M, Foxwell BM, et al. (1998) Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. J Immunol 160: 920-928.
43. Liu YW, Chen CC, Tseng HP, Chang WC, (2006) Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-kappaB-induced CCAAT/enhancer-binding protein delta in mouse macrophages. Cell Signal 18: 1492-1500.
44. Vaya A, Martinez TM, Reganon E, Vila V, Martinez SV, et al. (2008) Erythrocyte membrane composition in patients with primary hypercholesterolemia. Clin Hemorheol Microcirc 40: 289-294.
45. Ristic-Medic D, Suzic S, Vucic V, Takic M, Tepsic J, et al. (2009) Serum and erythrocyte membrane phospholipids fatty acid composition in hyperlipidemia: effects of dietary intervention and combined diet and fibrate therapy. Gen Physiol Biophys 28 Spec No: 190-199.
46. Koter M, Franiak I, Strychalska K, Broncel M, Chojnowska-Jezierska J, (2004) Damage to the structure of erythrocyte plasma membranes in patients with type-2 hypercholesterolemia. Int J Biochem Cell Biol 36: 205-215.
47. Seres I, Freyss-Beguin M, Mohacsi A, Kozlovsky B, Simon J, et al. (1996) Alteration of lymphocyte membrane phospholipids and intracellular free calcium concentrations in hyperlipidemic subjects. Atherosclerosis 121: 175-183.
48. Ghosh J, Das S, Guha R, Ghosh D, Naskar K, et al. (2012) Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol. J Lipid Res 53: 2560-2572.
49. Zhang X, Hurng J, Rateri DL, Daugherty A, Schmid-Schonbein GW, et al. (2011) Membrane cholesterol modulates the fluid shear stress response of polymorphonuclear leukocytes via its effects on membrane fluidity. Am J Physiol Cell Physiol 301: C451-460.
50. Hajishengallis G, Tapping RI, Harokopakis E, Nishiyama S, Ratti P, et al. (2006) Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell Microbiol 8: 1557-1570.
51. Triantafilou M, Morath S, Mackie A, Hartung T, Triantafilou K, (2004) Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J Cell Sci 117: 4007-4014.
52. Triantafilou M, Gamper FG, Lepper PM, Mouratis MA, Schumann C, et al. (2007) Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell Microbiol 9: 2030-2039.
53. Hajishengallis G, Wang M, Harokopakis E, Triantafilou M, Triantafilou K, (2006) Porphyromonas gingivalis fimbriae proactively modulate beta2 integrin adhesive activity and promote binding to and internalization by macrophages. Infect Immun 74: 5658-5666.
54. Assinger A, Laky M, Schabbauer G, Hirschl AM, Buchberger E, et al. (2011) Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2. J Thromb Haemost 9: 799-809.
55. Hajishengallis G, McIntosh ML, Nishiyama SI, Yoshimura F (2012) Mechanism and implications of CXCR4-mediated integrin activation by Porphyromonas gingivalis.LID. Mol Oral Microbiol. doi:10.1111/omi.12021.
56. Wang M, Hajishengallis G, (2008) Lipid raft-dependent uptake, signalling and intracellular fate of Porphyromonas gingivalis in mouse macrophages. Cell Microbiol 10: 2029-2042.
57. Bostanci N, Thurnheer T, Belibasakis GN, (2011) Involvement of the TREM-1/DAP12 pathway in the innate immune responses to Porphyromonas gingivalis. Mol Immunol 49: 387-394.
58. Gibot S, Kolopp-Sarda MN, Bene MC, Bollaert PE, Lozniewski A, et al. (2004) A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 200: 1419-1426.
59. Su L, Han B, Liu C, Liang L, Jiang Z, et al. (2012) Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis 12: 157.
60. Wu Y, Wang F, Fan X, Bao R, Bo L, et al. (2012) Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis. Crit Care 16: R229.
61. Sato T, Yamano Y, Tomaru U, Shimizu Y, Ando H, et al. (2013) Serum level of soluble triggering receptor expressed on myeloid cells-1 as a biomarker of disease activity in relapsing polychondritis. Mod Rheumatol.
62. Jung YS, Park JJ, Kim SW, Hong SP, Kim TI, et al. (2012) Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases. Dig Liver Dis 44: 897-903.
63. Bisson C, Massin F, Lefevre PA, Thilly N, Miller N, et al. (2012) Increased gingival crevicular fluid levels of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in severe periodontitis. J Clin Periodontol 39: 1141-1148.
64. Bostanci N, Ozturk VO, Emingil G, Belibasakis GN, (2013) Elevated oral and systemic levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in periodontitis. J Dent Res 92: 161-165.
65. Lamster IB, Karabin SD, (1992) Periodontal disease activity. Curr Opin Dent 2: 39-52.